Filing Details
- Accession Number:
- 0001181431-14-034525
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-20 20:30:59
- Reporting Period:
- 2014-10-16
- Filing Date:
- 2014-10-20
- Accepted Time:
- 2014-10-20 20:30:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124140 | Exact Sciences Corp | EXAS | Services-Commercial Physical & Biological Research (8731) | 204782291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199735 | Sally Crawford | C/O Exact Sciences Corp. 441 Charmany Drive Madison WI 53719 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-16 | 5,000 | $2.24 | 217,341 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-10-16 | 15,000 | $2.09 | 232,341 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-10-16 | 7,768 | $3.00 | 240,109 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-16 | 27,768 | $22.84 | 212,341 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-10-17 | 7,232 | $3.00 | 219,573 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-10-17 | 15,000 | $0.71 | 234,573 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-10-17 | 5,536 | $3.43 | 240,109 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-17 | 27,768 | $23.68 | 212,341 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-10-20 | 2,131 | $3.43 | 214,472 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-10-20 | 15,772 | $8.52 | 230,244 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-10-20 | 5,257 | $8.52 | 235,501 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-10-20 | 4,608 | $10.18 | 240,109 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-20 | 27,768 | $23.93 | 212,341 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-16 | 5,000 | $0.00 | 15,000 | $2.24 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-16 | 15,000 | $0.00 | 15,000 | $2.09 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-16 | 7,768 | $0.00 | 15,000 | $3.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-17 | 7,232 | $0.00 | 7,232 | $3.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-17 | 15,000 | $0.00 | 15,000 | $0.71 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-17 | 5,536 | $0.00 | 7,667 | $3.43 |
| Common Stock | Stock Option (right to buy | Disposition | 2014-10-20 | 2,131 | $0.00 | 2,131 | $3.43 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-20 | 15,772 | $0.00 | 15,772 | $8.52 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-20 | 5,257 | $0.00 | 5,257 | $8.52 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-20 | 4,608 | $0.00 | 4,608 | $10.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2006-07-22 | 2015-07-22 | No | 4 | M | Direct |
| 0 | 2007-07-21 | 2016-07-21 | No | 4 | M | Direct |
| 7,232 | 2008-08-10 | 2017-08-10 | No | 4 | M | Direct |
| 0 | 2008-08-10 | 2017-08-10 | No | 4 | M | Direct |
| 0 | 2009-07-18 | 2018-07-18 | No | 4 | M | Direct |
| 2,131 | 2011-07-16 | 2020-07-16 | No | 4 | M | Direct |
| 0 | 2011-07-16 | 2020-07-16 | No | 4 | M | Direct |
| 0 | 2014-07-28 | 2021-07-28 | No | 4 | M | Direct |
| 0 | 2012-07-28 | 2021-07-28 | No | 4 | M | Direct |
| 0 | 2013-07-26 | 2022-07-26 | No | 4 | M | Direct |
Footnotes
- The exercise of these options and the subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted September 8, 2014. The sales of shares pursuant to this 10b5-1 trading plan and disclosed on this Form 4 reflect the execution of all shares subject to the 10b5-1 trading plan. As a result, the 10b5-1 trading plan has been terminated effective as of the filing of this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.65 to $23.11, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $24.02, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.72 to $24.05, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
Billionaire Hedge Funds
